In fact, Choo et al., reported that 2-hydroxyethyl 5-chloro-4,5-didehydrojasmonate (J11-Cl), a PPARγ agonist, reduced the symptoms of DSS-induced colitis, increased the activity of PPARγ and increased the expression of anti-inflammatory cytokines [67]. This evidence concerns the gene PPARG and colitis.